nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
NAFLD is on the rise. Here’s what to know about the disease’s various stages, as well as prevention and treatment guidelines
La incidencia de EHGNA está aumentando. Esto es lo que debe saber sobre las distintas etapas de la enfermedad, así como sobre las recomendaciones de prevención y tratamiento.
NAFLD and NASH:
Up to 25 percent of people in the United States are affected by nonalcoholic fatty liver disease (NAFLD), which is characterized by accumulation of fat in the liver that is not attributed to alcohol. Approximately one-third of NAFLD patients will develop nonalcoholic steatohepatitis (NASH), a severe form of NAFLD with inflammation that is associated with increased risk for liver cirrhosis, end-stage liver disease and primary liver cancer. More than 10 percent of adults may be living with NASH. READ MORE